MaxCyte, Inc

MaxCyte® Launches ExPERT™ Family of Instruments, Providing a Unifying Technology Platform from Concept to Commercialization for the Next Generation of Cellular Therapies
Test & Measurement

MaxCyte® Launches ExPERT™ Family of Instruments, Providing a Unifying Technology Platform from Concept to Commercialization for the Next Generation of Cellular Therapies

Gaithersburg, Md., April 8, 2019 /PRNewswire/ -- MaxCyte, the global clinical-stage cell-based medicines and life sciences company, announced today the launch of the new ExPERT™ technology platform. This family of instruments – the ATx, STx and GTx – represents the next generation of the industry's leading, clinically validated Flow Electroporation® technology for complex cellular...

Read More »
MaxCyte-® Launches ExPERT™ Family of Instruments, Providing a Unifying Technology Platform from Concept to Commercialization for the Next Generation of Cellular Therapies
Test & Measurement

MaxCyte-® Launches ExPERT™ Family of Instruments, Providing a Unifying Technology Platform from Concept to Commercialization for the Next Generation of Cellular Therapies

Gaithersburg, Md., April 8, 2019 /PRNewswire/ -- MaxCyte, the global clinical-stage cell-based medicines and life sciences company, announced today the launch of the new ExPERT™ technology platform. This family of instruments – the ATx, STx and GTx – represents the next generation of the industry's leading, clinically validated Flow Electroporation® technology for complex cellular...

Read More »
Laboratory and Research Supplies and Equipment

Scalable System customizes stem cells for therapeutic use.

GT(TM) Flow Transfection System enables accelerated and efficient transfection of any primary cell or cell line with greater than 90% cell viability following loading with range of molecules - proteins, drugs, plasmids, mRNA, miRNA, siRNA - or combinations thereof at volumes up to tens of billion cells. With processing time of under 30 min, solution enables consistent cGMP-compliant cell...

Read More »
Laboratory and Research Supplies and Equipment

Scalable System customizes stem cells for therapeutic use.

GT(TM) Flow Transfection System enables accelerated and efficient transfection of any primary cell or cell line with greater than 90% cell viability following loading with range of molecules - proteins, drugs, plasmids, mRNA, miRNA, siRNA - or combinations thereof at volumes up to tens of billion cells. With processing time of under 30 min, solution enables consistent cGMP-compliant cell...

Read More »

Transfection System speeds cell-based assay development.

Used for reagent-free preparative transfection based on flow electroporation technology, ITF Inline Transfection System is sterile, closed system available for drug discovery and screening applications. Validated and scalable platform enables transient transfection of any kind of cell or cell line with any molecule at scales ranging from micro-liters to liter volumes. It can be used to transfect...

Read More »

Transfection System speeds cell-based assay development.

Used for reagent-free preparative transfection based on flow electroporation technology, ITF Inline Transfection System is sterile, closed system available for drug discovery and screening applications. Validated and scalable platform enables transient transfection of any kind of cell or cell line with any molecule at scales ranging from micro-liters to liter volumes. It can be used to transfect...

Read More »
Company News

MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ's Adoptive Cell Therapy Programs

GAITHERSBURG, Md. and CAMBRIDGE, Mass., Dec. 4, 2019 /PRNewswire/ -- MaxCyte, the global cell-based therapies and life sciences company, and KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to achieve higher probabilities of success in drug development, announced today that the companies have entered into a new development and commercialization...

Read More »
Company News

MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ's Adoptive Cell Therapy Programs

GAITHERSBURG, Md. and CAMBRIDGE, Mass., Dec. 4, 2019 /PRNewswire/ -- MaxCyte, the global cell-based therapies and life sciences company, and KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to achieve higher probabilities of success in drug development, announced today that the companies have entered into a new development and commercialization...

Read More »
MaxCyte® Launches ExPERT™ Family of Instruments, Providing a Unifying Technology Platform from Concept to Commercialization for the Next Generation of Cellular Therapies
Test & Measurement

MaxCyte® Launches ExPERT™ Family of Instruments, Providing a Unifying Technology Platform from Concept to Commercialization for the Next Generation of Cellular Therapies

Gaithersburg, Md., April 8, 2019 /PRNewswire/ -- MaxCyte, the global clinical-stage cell-based medicines and life sciences company, announced today the launch of the new ExPERT™ technology platform. This family of instruments – the ATx, STx and GTx – represents the next generation of the industry's leading, clinically validated Flow Electroporation® technology for complex cellular...

Read More »
MaxCyte-® Launches ExPERT™ Family of Instruments, Providing a Unifying Technology Platform from Concept to Commercialization for the Next Generation of Cellular Therapies
Test & Measurement

MaxCyte-® Launches ExPERT™ Family of Instruments, Providing a Unifying Technology Platform from Concept to Commercialization for the Next Generation of Cellular Therapies

Gaithersburg, Md., April 8, 2019 /PRNewswire/ -- MaxCyte, the global clinical-stage cell-based medicines and life sciences company, announced today the launch of the new ExPERT™ technology platform. This family of instruments – the ATx, STx and GTx – represents the next generation of the industry's leading, clinically validated Flow Electroporation® technology for complex cellular...

Read More »
Laboratory and Research Supplies and Equipment

Scalable System customizes stem cells for therapeutic use.

GT(TM) Flow Transfection System enables accelerated and efficient transfection of any primary cell or cell line with greater than 90% cell viability following loading with range of molecules - proteins, drugs, plasmids, mRNA, miRNA, siRNA - or combinations thereof at volumes up to tens of billion cells. With processing time of under 30 min, solution enables consistent cGMP-compliant cell...

Read More »
Laboratory and Research Supplies and Equipment

Scalable System customizes stem cells for therapeutic use.

GT(TM) Flow Transfection System enables accelerated and efficient transfection of any primary cell or cell line with greater than 90% cell viability following loading with range of molecules - proteins, drugs, plasmids, mRNA, miRNA, siRNA - or combinations thereof at volumes up to tens of billion cells. With processing time of under 30 min, solution enables consistent cGMP-compliant cell...

Read More »

Transfection System speeds cell-based assay development.

Used for reagent-free preparative transfection based on flow electroporation technology, ITF Inline Transfection System is sterile, closed system available for drug discovery and screening applications. Validated and scalable platform enables transient transfection of any kind of cell or cell line with any molecule at scales ranging from micro-liters to liter volumes. It can be used to transfect...

Read More »

Transfection System speeds cell-based assay development.

Used for reagent-free preparative transfection based on flow electroporation technology, ITF Inline Transfection System is sterile, closed system available for drug discovery and screening applications. Validated and scalable platform enables transient transfection of any kind of cell or cell line with any molecule at scales ranging from micro-liters to liter volumes. It can be used to transfect...

Read More »

All Topics